Results 111 to 120 of about 32,408 (167)

Regulatory B cell-related gene signature predicts prognosis and immune landscape in head and neck squamous cell carcinoma. [PDF]

Front Immunol
He J, Pang K, Zhou Z, Yang C, Chen Y, He S, Wang F, Li P.   +7 more
europepmc   +1 more source

A Pan-Cancer Transcriptomic Signature for Conserved Molecular Programs Underlying Premalignant-Malignant Progression Across Common Carcinomas. [PDF]

Dent J (Basel)
Kazemi KS, Miyazawa M, Hanemann JAC, Ionta M, Oliveira PF, Leask A, Franca CM, Sperandio FF.   +7 more
europepmc   +1 more source

A novel immune-related gene signature stratifies prognosis and characterizes the tumor immune microenvironment in head and neck squamous cell carcinoma. [PDF]

Front Cell Dev Biol
Li P, Pang K, Zhou Z, Yang C, Chen Y, Wu Y, Wang F, He J.   +7 more
europepmc   +1 more source

Significance of SLC1A5 expression in head and neck squamous cell carcinoma: A bioinformatics and in-vitro analysis. [PDF]

J Oral Biol Craniofac Res
Kaarunya S, Sinduja P, Yuwanati M, Mullainathan S.   +3 more
europepmc   +1 more source

Identification and validation of disulfidptosis-related gene signature revealed DKK1 as a therapeutic target in head and neck squamous cell carcinoma. [PDF]

Sci Rep
Li Z, Xu W, Li Z, Yu Z, Wang J.
europepmc   +1 more source

MMP1 Modulates Head and Neck Squamous Cell Carcinoma Progression and Therapeutic Response Via Tumour Microenvironment. [PDF]

Int Dent J
Mao C, Chen D, Lai Y, Lu M, Wang C.
europepmc   +1 more source

Enhanced CT‑based radiomics model to predict CD40LG expression and clinical prognosis in head and neck squamous cell carcinoma. [PDF]

Braz J Otorhinolaryngol
Fan L, Shi L, Yuan H, Wang Z, Wang J, Xian F, Mu Y.   +6 more
europepmc   +1 more source

Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignancies. [PDF]

Cancer
Kim TM, Williamson SK, Papadopoulos KP, Hamid O, Dy GK, McDermott R, Birnbaum A, Kaczmar JM, Lakhani N, Rischin D, Sarker D, Dowlati A, Zhu XH, Malhotra J, Pouliot JF, Mani J, Brennan L, Fang F, Chen S, Salvati M, Lowy I, Khaled A, Lewis KD, Kroog G, Fury MG, Cho BC.   +25 more
europepmc   +1 more source

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy [PDF]

Cells, 2020
Head and neck squamous cell carcinomas (HNSCC) are a heterogeneous group of malignant tumours typically caused by alcohol and tobacco consumption, although an increasing number of HNSCC arise due to persistent infection with high-risk human papilloma virus (HPV).
Adrian Von Witzleben, Chuan Wang, Simon Laban   +2 more
exaly   +4 more sources